Command Palette

Search for a command to run...

Clinical Trials · NCT05813249

Semaglutide in Nonalcoholic Fatty Liver Disease

CompletedPhase 4Semaglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Zagazig University
Enrollment
180
Start date
Feb 2023
Locations
1 site, Egypt
Primary endpoint
NAFLD regression
View Semaglutide compound reference